Novel Lupus Drug Clears Phase II Hurdle

MedPage Today) — BARCELONA — A small-molecule oral drug shaping up as a first-in-class to treat various forms of lupus performed well in a phase II trial, despite — or perhaps even because of — missing its primary endpoint, a presentation…